Pancreatic cysts represent a growing public health dilemma, particularly as our population ages and cross-sectional imaging becomes more widespread. Mucinous cysts are precancerous and carry the potential of developing into pancreatic cancer, which carries an extremely poor prognosis. Determining which cysts will develop cancer may be challenging, and surgical resection of the pancreas carries significant morbidity. Endoscopic ultrasound-guided chemoablation of neoplastic pancreatic cysts is a minimally invasive and evolving technique with different approaches which have varying levels of efficacy and safety. The goal of this seminar is to review the rationale for cyst ablation and discuss prior and current research on cyst ablation techniques as well as reviewing efficacy, indications, contraindications, and optimal patient selection.
Release Date: March 25, 2022Viewing Time: 1.5 hours
Matthew T. Moyer MD, MS, FASGE Professor, Department of Medicine Division of Gastroenterology and HepatologyCancer Institute, Next-Generation TherapiesPenn State Cancer InstituteHershey, Pennsylvania, USA
John M. DeWitt MD, FASGEProfessor of MedicineDepartment of MedicineDivision of Gastroenterology and HepatologyIU School of MedicineIndianapolis, Indiana, USA